ImmunityBio reports Q1 results

ImmunityBio has released its financial results for the first quarter. Specific details regarding revenue, profitability, and operational performance were not provided in the initial announcement. Investors and analysts will be reviewing these results to assess the company's financial health and its progress in its development pipeline. The report is crucial for understanding the company's current standing and future outlook in the biotechnology sector.